Less Invasive Ventricular Enhancement™ (LIVE™)
About Us
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches.
Less Invasive Ventricular Enhancement or LIVE® is a revolutionary procedure which offers a new treatment option for patients suffering from ischemic cardiomyopathy. The Revivent TC® TransCatheter Ventricular Enhancement System is a safer and less invasive alternative to surgical ventricular remodeling. It was developed for the purpose of excluding discrete left ventricular scar, thereby reconfiguring abnormal cardiac geometry that leads to dysfunction. Our unique system provides a new solution for multidisciplinary heart teams and their patients by its proven clinical improvements.
Our Management Team
Our Board of Directors
- David Richmond – Founding partner and chairman of Richmond Brothers, Inc.
- Mike Taglich – Taglich Brothers Investment Banking
